Inmune Bio, Inc. (INMB)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch INMB
See up to 3 months of INMB. The 7-day demo opens the 1M and 3M ranges and puts INMB on your watchlist.
Start 7-day demoLatest INMB insider trades
About Inmune Bio, Inc. (INMB)
The SEC lists Inmune Bio, Inc. under CIK 0001711754, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
INMB Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 200,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
INMB insider transactions (Form 4)
12026 Form 4 filings on record, the earliest from Dec 9, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ronnie Duane Clark - Director | Grant or award | Stock Options | 100,000 | $0.00 | - | |
| James Sapirstein - Director | Grant or award | Stock Options | 100,000 | $0.00 | - | |
| Scott Juda - Director | Other | Common Stock Purchase Warrant | 14,801 | $0.13 | $2K | |
| Scott Juda - Director | Option exercise | Common Stock | 14,801 footnote F1 | $1.40 | $21K | |
| ||||||
| Mark William Lowdell - Officer | Other | Common Stock Purchase Warrant | 7,211 | $0.13 | $901 | |
| Mark William Lowdell - Officer | Option exercise | Common Stock | 7,211 footnote F1 | $1.40 | $10K | |
| ||||||
| David J. Moss - Officer | Other | Common Stock Purchase Warrant | 9,014 | $0.13 | $1K | |
| David J. Moss - Officer | Option exercise | Common Stock | 9,014 footnote F1 | $1.40 | $13K | |
| ||||||
| Mark William Lowdell - Officer | Grant or award | Option (right to buy) | 600,000 | $0.00 | - | |
| Cory Randall Ellspermann - Officer | Grant or award | Option (right to buy) | 300,000 | $0.00 | - | |
| Timothy J. Schroeder - Director | Grant or award | Option (right to buy) | 150,000 | $0.00 | - | |
| Scott Juda - Director | Grant or award | Option (right to buy) | 150,000 | $0.00 | - | |
| James Kelly Ganjei - Director | Grant or award | Option (right to buy) | 150,000 | $0.00 | - | |
| David J. Moss - Officer | Grant or award | Option (right to buy) | 750,000 | $0.00 | - | |
| Marcia Allen - Director | Grant or award | Option (right to buy) | 150,000 | $0.00 | - | |
| Timothy J. Schroeder - Director | Derivative | Stock Option (right to buy) | 19,025 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Grant or award | Stock Option (right to buy) | 19,025 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Derivative | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Derivative | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Grant or award | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Grant or award | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Derivative | Stock Option (right to buy) | 32,500 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Grant or award | Stock Option (right to buy) | 32,500 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Derivative | Stock Option (right to buy) | 12,500 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Grant or award | Stock Option (right to buy) | 12,500 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Derivative | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Derivative | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Grant or award | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Grant or award | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Derivative | Stock Option (right to buy) | 15,975 | - footnote F1 | - | |
| Timothy J. Schroeder - Director | Grant or award | Stock Option (right to buy) | 15,975 | - footnote F1 | - | |
| ||||||
| Mark William Lowdell - Officer | Grant or award | Stock Option (right to buy) | 400,000 | - footnote F1 | - | |
| Mark William Lowdell - Officer | Derivative | Stock Option (right to buy) | 180,000 | - footnote F1 | - | |
| Mark William Lowdell - Officer | Grant or award | Stock Option (right to buy) | 180,000 | - footnote F1 | - | |
| Mark William Lowdell - Officer | Derivative | Stock Option (right to buy) | 104,000 | - footnote F1 | - | |
| Mark William Lowdell - Officer | Grant or award | Stock Option (right to buy) | 104,000 | - footnote F1 | - | |
| Mark William Lowdell - Officer | Derivative | Stock Option (right to buy) | 140,000 | - footnote F1 | - | |
| Mark William Lowdell - Officer | Grant or award | Stock Option (right to buy) | 140,000 | - footnote F1 | - | |
| Mark William Lowdell - Officer | Derivative | Stock Option (right to buy) | 100,000 | - footnote F1 | - | |
| Mark William Lowdell - Officer | Grant or award | Stock Option (right to buy) | 100,000 | - footnote F1 | - | |
| Mark William Lowdell - Officer | Derivative | Stock Option (right to buy) | 400,000 | - footnote F1 | - | |
| ||||||
| Scott Juda - Director | Grant or award | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| Scott Juda - Director | Grant or award | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| Scott Juda - Director | Derivative | Stock Option (right to buy) | 32,500 | - footnote F1 | - | |
| Scott Juda - Director | Grant or award | Stock Option (right to buy) | 32,500 | - footnote F1 | - | |
| Scott Juda - Director | Derivative | Stock Option (right to buy) | 12,500 | - footnote F1 | - | |
| Scott Juda - Director | Grant or award | Stock Option (right to buy) | 12,500 | - footnote F1 | - | |
| Scott Juda - Director | Derivative | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| Scott Juda - Director | Derivative | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| Scott Juda - Director | Grant or award | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| Scott Juda - Director | Grant or award | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| Scott Juda - Director | Derivative | Stock Option (right to buy) | 15,975 | - footnote F1 | - | |
| Scott Juda - Director | Grant or award | Stock Option (right to buy) | 15,975 | - footnote F1 | - | |
| Scott Juda - Director | Derivative | Stock Option (right to buy) | 19,025 | - footnote F1 | - | |
| Scott Juda - Director | Grant or award | Stock Option (right to buy) | 19,025 | - footnote F1 | - | |
| Scott Juda - Director | Derivative | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| Scott Juda - Director | Derivative | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| ||||||
| James Kelly Ganjei - Director | Grant or award | Stock Option (right to buy) | 19,025 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Derivative | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Derivative | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Grant or award | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Grant or award | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Derivative | Stock Option (right to buy) | 32,500 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Grant or award | Stock Option (right to buy) | 32,500 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Derivative | Stock Option (right to buy) | 12,500 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Grant or award | Stock Option (right to buy) | 12,500 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Derivative | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Derivative | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Grant or award | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Grant or award | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Derivative | Stock Option (right to buy) | 15,975 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Grant or award | Stock Option (right to buy) | 15,975 | - footnote F1 | - | |
| James Kelly Ganjei - Director | Derivative | Stock Option (right to buy) | 19,025 | - footnote F1 | - | |
| ||||||
| Cory Randall Ellspermann - Officer | Grant or award | Stock Option (right to buy) | 75,000 | - footnote F1 | - | |
| Cory Randall Ellspermann - Officer | Derivative | Stock Option (right to buy) | 40,000 | - footnote F1 | - | |
| Cory Randall Ellspermann - Officer | Grant or award | Stock Option (right to buy) | 40,000 | - footnote F1 | - | |
| Cory Randall Ellspermann - Officer | Derivative | Stock Option (right to buy) | 30,000 | - footnote F1 | - | |
| Cory Randall Ellspermann - Officer | Derivative | Stock Option (right to buy) | 30,000 | - footnote F1 | - | |
| Cory Randall Ellspermann - Officer | Grant or award | Stock Option (right to buy) | 30,000 | - footnote F1 | - | |
| Cory Randall Ellspermann - Officer | Grant or award | Stock Option (right to buy) | 30,000 | - footnote F1 | - | |
| Cory Randall Ellspermann - Officer | Derivative | Stock Option (right to buy) | 70,000 | - footnote F1 | - | |
| Cory Randall Ellspermann - Officer | Grant or award | Stock Option (right to buy) | 70,000 | - footnote F1 | - | |
| Cory Randall Ellspermann - Officer | Derivative | Stock Option (right to buy) | 75,000 | - footnote F1 | - | |
| ||||||
| David J. Moss - Officer | Derivative | Stock Option (right to buy) | 400,000 | - footnote F1 | - | |
| David J. Moss - Officer | Grant or award | Stock Option (right to buy) | 400,000 | - footnote F1 | - | |
| David J. Moss - Officer | Derivative | Stock Option (right to buy) | 59,337 | - footnote F1 | - | |
| David J. Moss - Officer | Grant or award | Stock Option (right to buy) | 59,337 | - footnote F1 | - | |
| David J. Moss - Officer | Derivative | Stock Option (right to buy) | 275,000 | - footnote F1 | - | |
| David J. Moss - Officer | Grant or award | Stock Option (right to buy) | 275,000 | - footnote F1 | - | |
| David J. Moss - Officer | Derivative | Stock Option (right to buy) | 70,663 | - footnote F1 | - | |
| David J. Moss - Officer | Grant or award | Stock Option (right to buy) | 70,663 | - footnote F1 | - | |
| David J. Moss - Officer | Derivative | Stock Option (right to buy) | 160,000 | - footnote F1 | - | |
| David J. Moss - Officer | Derivative | Stock Option (right to buy) | 160,000 | - footnote F1 | - | |
| David J. Moss - Officer | Grant or award | Stock Option (right to buy) | 160,000 | - footnote F1 | - | |
| David J. Moss - Officer | Grant or award | Stock Option (right to buy) | 160,000 | - footnote F1 | - | |
| David J. Moss - Officer | Derivative | Stock Option (right to buy) | 130,000 | - footnote F1 | - | |
| David J. Moss - Officer | Grant or award | Stock Option (right to buy) | 130,000 | - footnote F1 | - | |
| David J. Moss - Officer | Derivative | Stock Option (right to buy) | 223,000 | - footnote F1 | - | |
| David J. Moss - Officer | Grant or award | Stock Option (right to buy) | 223,000 | - footnote F1 | - | |
| ||||||
| Marcia Allen - Director | Grant or award | Stock Option (right to buy) | 15,975 | - footnote F1 | - | |
| Marcia Allen - Director | Derivative | Stock Option (right to buy) | 19,025 | - footnote F1 | - | |
| Marcia Allen - Director | Grant or award | Stock Option (right to buy) | 19,025 | - footnote F1 | - | |
| Marcia Allen - Director | Derivative | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| Marcia Allen - Director | Derivative | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| Marcia Allen - Director | Grant or award | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| Marcia Allen - Director | Grant or award | Stock Option (right to buy) | 35,000 | - footnote F1 | - | |
| Marcia Allen - Director | Derivative | Stock Option (right to buy) | 32,500 | - footnote F1 | - | |
| Marcia Allen - Director | Grant or award | Stock Option (right to buy) | 32,500 | - footnote F1 | - | |
| Marcia Allen - Director | Derivative | Stock Option (right to buy) | 12,500 | - footnote F1 | - | |
| Marcia Allen - Director | Grant or award | Stock Option (right to buy) | 12,500 | - footnote F1 | - | |
| Marcia Allen - Director | Derivative | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| Marcia Allen - Director | Grant or award | Stock Option (right to buy) | 108,000 | - footnote F1 | - | |
| Marcia Allen - Director | Derivative | Stock Option (right to buy) | 15,975 | - footnote F1 | - | |
| ||||||
| Raymond Joseph Tesi - Officer | Grant or award | Option (right to buy) | 226,000 | $0.00 | - | |
| Mark William Lowdell - Officer | Grant or award | Option (right to buy) | 140,000 | $0.00 | - | |
| Scott Juda - Director | Grant or award | Option (right to buy) | 32,500 | $0.00 | - | |
| Timothy J. Schroeder - Director | Grant or award | Option (right to buy) | 32,500 | $0.00 | - | |
| James Kelly Ganjei - Director | Grant or award | Option (right to buy) | 32,500 | $0.00 | - | |
| David J. Moss - Officer | Grant or award | Option (right to buy) | 223,000 | $0.00 | - | |
| Marcia Allen - Director | Grant or award | Option (right to buy) | 32,500 | $0.00 | - | |
Item 5.02, 8.01, 9.01
Item 8.01, 9.01
Item 1.01, 9.01
Item 8.01, 9.01
INMB insider trading FAQ
What is the latest insider trade for INMB?
Inmune Bio, Inc. (INMB) had 2 insider filings in the last 90 days, with the most recent on 2026-09-23. The full record for INMB runs to 26 Form 4 filings, the earliest from 2024-12-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying INMB stock?
No insider purchases of INMB were filed in the last 90 days.
How many insiders are selling INMB stock?
No insider sales of INMB were filed in the last 90 days.
Where can I see INMB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects INMB Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Ronnie Duane Clark view on EDGAR
- - James Sapirstein view on EDGAR
- - Scott Juda view on EDGAR
- - Mark William Lowdell view on EDGAR
- - David J. Moss view on EDGAR
- - Mark William Lowdell view on EDGAR
- - Cory Randall Ellspermann view on EDGAR
- - Timothy J. Schroeder view on EDGAR
- - Scott Juda view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where INMB's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow INMB with a 7-day demo
- INMB on your watchlist
- Every INMB Form 4 filing on record
- Up to 3 months of INMB price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
